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association between liver steatosis and metabolic disease 
(4, 5). A more detailed understanding of lipid deposition 
likely will reveal even more specific associations with dis-
ease. Unfortunately, data on lipid levels in specific cell 
types within tissues is scarce. This is in part due to limited 
options to assess lipid levels in specific cells in tissues com-
posed of multiple cell types.
Imaging has been used, but has significant disadvan-
tages. First, it is either subjective or requires laborious 
schemes to quantify lipids. Second, heterogeneity within 
a sample and the requirement for high magnification to 
see small lipid droplets makes data collection tedious. 
Third, even with schemes to quantify signals between 
samples, the absolute amount of lipids per cell is diffi-
cult to estimate. Flow cytometry (FC) does not share 
these disadvantages; it is automated and quantitative, is 
not subject to observer bias, and does not analyze a mi-
croscopic part of a heterogeneous tissue. Not surpris-
ingly, FC has been used to assess lipid levels in mixed 
populations of cells (6). However, the usefulness of FC is 
diminished because, like quantitative PCR and many 
other assays, units are arbitrary and differ between instru-
ments and experiments. Further, unlike many biochemical 
assays, which can be performed on banked frozen samples, 
FC is generally performed on live cells. Finally, whereas 
most other biologic assays have strategies to normalize 
measurements between experiments, no such normaliza-
tion has been devised for FC lipid measurements. These 
constraints limit the usefulness of FC in any study requir-
ing measurements before and after treatment. We show 
here that fluorescence intensity measured by FC in-
creases linearly with triacylglycerol (TG) levels in cells, 
that normalizing to a control condition can improve com-
parisons between experiments, and that fluorescence 
intensity of a single cell type in a mixed population can 
be assessed.
Abstract Interest in measuring tissue lipids has increased 
as the link between fat-laden tissues and metabolic disease 
has become obvious; however, linking disease to a specific 
cell type within a tissue has been hampered by methodologi-
cal limitations. Flow cytometry (FC) has been used to assess 
relative lipid levels in cells. Unfortunately, its usefulness is 
limited because comparisons between samples generated 
over several hours is problematic. We show that: 1) in lipo-
philic fluorophore stained cells, fluorescence intensity mea-
sured by FC reflects lipid levels; 2) this technique can be 
used to assess lipid levels in a mixed cell population; 3) nor-
malizing to a control condition can decrease experiment- 
to-experiment variation; and 4) fluorescence intensity 
increases linearly with lipid levels. This allows triacylglycerol 
(TG) mass to be estimated in mixed cell populations compar-
ing cells with known fluorescence and TG levels. We exploited 
this strategy to estimate lipid levels in monocytes within a 
mixed population of cells isolated from human blood. Using 
this strategy, we also confirmed that perilipin (PLIN)1 in-
creases TG accumulation by ectopically expressing fluo-
rescently tagged PLIN1 in Huh7 cells. In both examples, 
biochemically assaying for TG in specific cell populations 
is problematic due to limited cell numbers and isolation 
challenges.  Other advantages are discussed.—Wolins, N. E., 
K. N. DeHaan, V. Cifarelli, and A. K. Stoeckman. Normalized 
neutral lipid quantitation by flow cytometry. J. Lipid Res. 
2018. 59: 1294–1300.
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cytes • triacylglycerol • perilipin
With industrialization came greater food availability, 
longer life span, and the decreased need for physical 
activity. There has been a subsequent increase in adipos-
ity, tissue steatosis, and metabolic disease (1–3). Obesity 
has long been associated with an increased prevalence of 
metabolic disease and recent studies reveal an even stronger 
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MATERIALS AND METHODS
Cell culture and FA treatment
AML-12 mouse hepatocytes were cultured in DMEM/F12 con-
taining 10% FBS, antibiotics, and 0.1% Insulin-Transferrin-
Selenium (Thermo Fisher 41400-045). HEK293 and Huh7 cells 
were cultured in DMEM containing 10% FBS and antibiotics. 
U937 cells were cultured in RPMI-1640 with 10% FBS and antibi-
otics. The FA, oleate, was complexed with FA-free BSA at 8:1 or 
5.5:1 molar ratio, as indicated in the figure legends (7, 8).
Flow cytometry
Cells were treated as described in the figure legends. At the 
time of harvest, cells were trypsinized and washed once with PBS, 
followed by staining with either the live cell method or the fixed 
cell method.
Live cell method. Cells were stained with 1 ml PBS containing 
10 g of BODIPY® 493/503 (BD) (Thermo Fisher D3922) for 
15 min at room temperature. Cells were then washed once with PBS 
before being analyzed on a Partec CyFlow Space ML flow cytometer.
Fixed cell method. Cells were trypsinized and fixed with 4% 
formaldehyde for 20 min at room temperature. Cells were stained 
with 20 ng/ml BD for 30 min, washed three times with PBS, and 
analyzed using an LSR Fortessa cytometer (BD Bioscience) and 
FlowJo software (FlowJo LLC, Ashland, OR).
Fluorescence microscopy
Fluorescence microscopy was performed as described previ-
ously (7). In brief, 3.5 × 105 cells were plated onto 22 mm square 
glass coverslips in 6-well tissue culture plates containing growth 
medium supplemented with FA. After 24 h, the medium was re-
moved and cells were fixed in 3% paraformaldehyde. Fixed cells 
were washed four times with PBS and then 2 ml of microscopy 
buffer with 20 l of 1 mg/ml BD were added to each well for 1 h 
at room temperature in the dark. Cells on coverslips were again 
washed four times with PBS followed by mounting to slides with 
ProLong® Gold antifade reagent with DAPI. Slides were imaged 
with a Nikon Eclipse TE2000-U microscope. Images were cap-
tured with a Photometrics CoolSnap cf camera using MetaMorph 
software (Molecular Devices, Downingtown, PA).
Triacylglycerol assay
An aliquot of the cells grown under each condition was assayed 
for TG. Cells were trypsinized, washed once with PBS, resus-
pended in PBS with 10 mM EDTA, and then counted. Cells were 
divided in triplicate into 13 × 100 mm glass tubes in a final volume 
of 200 l. Triolein standards (Sigma T7140) were also prepared 
in a final volume of 200 l PBS/10 mM EDTA in 13 × 100 mm 
glass tubes. TGs were extracted and quantified as previously de-
scribed (9). Briefly, 2 ml of isopropanol:hexane:water (40:10:1) 
were added to cells or standards and the samples were vortexed, 
covered, and incubated at room temperature for 30 min. Then, 
500 l of a 1:1 mixture of hexane:diethylether were added to the 
samples followed by vortexing and incubating for an additional 
10 min at room temperature. Next, 1 ml of water was added to 
samples, tubes were vortexed, and layers were allowed to separate 
at room temperature while covered for 30–45 min. Using Pasteur 
pipettes, the top layer was transferred to 12 × 75 mm glass tubes 
and dried under N2 to completion. Following the drying step, 
400 l of Infinity triglyceride reagent (Thermo Scientific TR22421) 
were added to each tube and vortexed. Tubes were covered and 
incubated for 90 min at 37°C with shaking at 250 rpm. Finally, 
300 l of each sample were transferred to 96-well plates and absor-
bance was measured at 540 nm using a microplate reader. To de-
termine whether fixing cells affected the TG measurement, we 
quantified TG in fixed and unfixed cells from the same batch of 
Huh7 cells incubated in 2 mM FA. We measured 159 ± 10.7 pg/
cell (n = 6) and 160 ± 3.37 pg/cell (n = 5) in the unfixed and fixed 
cells (P = 0.80), respectively.
Peripheral blood mononuclear cell isolation
Blood was drawn and collected in BD Vacutainer Lithium Hep-
arin tubes (Thermo Fisher 02-689-7). Freshly isolated blood was 
diluted with an equal volume of PBS and layered on a Ficoll-
Paque™ PLUS cushion according to the manufacturer’s instruc-
tions (GE Healthcare 17-1440-02). After a 40 min spin at 400 g (no 
brake), peripheral blood mononuclear cells (PBMCs) were col-
lected, washed, and incubated with the following anti-human an-
tibody cocktail: CD45 (1:200), HLA-DR (1:200), CD11c (1:1,000), 
and CD14 (1:60) (all from Biolegend, San Diego, CA) for 20 min 
at 4°C. Cells were then washed, fixed in BD Cytofix buffer (BD Bio-
science), and stained with 20 ng/ml BD for 30 min at room tem-
perature (fixed cell method). Cells were analyzed with an LSR 
Fortessa cytometer. These experiments were approved by the Bethel 
Institutional Review Board or monitored by the Human Research 
Protection Office at Washington University School of Medicine in 
St. Louis, MO (clinicaltrials.gov number: NCT01538836).
Red fluorescent protein-perilipin 1 fusion construct
The red fluorescent protein (RFP)-perilipin (PLIN)1 expression 
construct was made by replacing the sequence encoding enhanced 
green fluorescent protein (eGFP) with that of monomeric RFP 
(10) in the previously described peGFP-C2-PLIN1 construct (11). 
The sequences linking the vector to RFP-PLIN1 are cgctagcgctac-
cggtcgccaccATG and aag agc TGAaagcttcgaa and the sequence 
that links RFP to PLIN1 is cac ctg ttc ctg gag / atc tca ata aac. The 
start and stop sites are capitalized, “/” shows the junction between 
the RFP and PLIN1, and spaces in the sequence indicate codons.
RFP-PLIN1 transfection
Huh7 cells were grown to 60–80% confluence and then trans-
fected with RFP-PLIN1 using 7 g RFP-PLIN1 in 1.2 ml Opti-MEM 
(Thermo Fisher 11668027) and 30 l of Lipofectamine 2000 in 
1.2 ml Opti-MEM (Thermo Fisher 31985062). Opti-MEM contain-
ing the DNA and Lipofectamine were combined, incubated for 
10 min, and then added to cells (400 l/well to a 6-well plate or 
2.4 ml to a 100 mm plate). Transfection medium was replaced 
after 6 h with medium containing 100 M FA.
RESULTS
Clinicians and physiologists work with tissues composed 
of multiple cell types. Traditionally, lipid levels were as-
sessed biochemically in the whole tissue or in specific cell 
types by microscopy using lipophilic dyes. Microscopy and 
FC measure arbitrary fluorescent units, which vary with the 
day and between instruments. This makes comparisons be-
tween experiments performed at separate times problem-
atic. We sought to develop a FC-based method to assay 
relative lipid levels in specific cell types within a mixed cell 
population, which does not require samples to be assayed 
in parallel for comparison.
FC assesses relative lipid levels of a single cell type within 
a mixed population
The first goal required that relative lipid levels of a 
single cell type be assessable in a mixed cell population. To 
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generate cells with different TG levels, we cultured kidney 
cells (HEK293) in 100 M FA and hepatocytes (AML-12) 
in 400 M FA. As expected, fluorescence microscopy 
showed that AML-12 cells contained more and larger TG 
droplets than HEK293 cells (Fig. 1A). We then mixed these 
cells and assessed size and granularity by forward scatter 
(FSC) and side scatter (SSC), respectively. We gated intact 
cells away from debris (large gate Fig. 1B). Within this gate, 
we identified two SSC-resolvable cell populations (Fig. 1B, 
upper left). We then analyzed the incorporation of a lipo-
philic dye by assessing BD fluorescence in the FITC chan-
nel and observed two distinct peaks (Fig. 1B, upper right). 
When gated separately, the cell population with increased 
SSC (internal complexity likely due to increased TG drop-
lets) had a mean BD-dependent mean fluorescence inten-
sity (BDMFI) of 34.7 (Fig. 1B, lower right), approximately 
5-fold higher than the other cell population (BDMFI = 7.3; 
Fig. 1B, lower left). To confirm the identity of the cell pop-
ulations, HEK293 cells and AML-12 cells were analyzed 
individually and BDMFIs were determined at 8.9 and 36.5, 
respectively (data not shown). As expected, the AML-12 
cells cultured with a higher concentration of FA had in-
creased SSC and BDMFI.
Normalizing data between experiments
Comparing to cells with known lipid levels. Lipid loading 
increased cell lipid droplet number and BDMFI (Fig. 1). 
To determine whether there is a quantitative relationship 
between TG and BDMFI, we generated cells with different 
TG levels by varying the FA concentration in their media 
and then measuring their average mass of TG/cell and 
BDMFI. Figure 2 shows that a linear relationship exists 
between TG mass and BDMFI within a cell type, regardless 
of whether the cells were analyzed live (Fig. 2A) or after 
fixation (Fig. 2B). Further, Fig. 3A shows that BDMFI in-
creased at a similar rate independent of cell type [Huh7 
slope = 51 ± 6 (fg/cell)/BDMFI and U937 slope = 49 ± 7 
(fg/cell)/BDMFI]. However, non-TG-dependent BDMFI 
(the intercepts) appeared to vary between cell types. Linear 
regression indicated that the TG-independent BDMFI 
Fig. 1. FC can resolve a mixed cell population into 
cells with high lipid levels or low lipid levels. A: 
HEK293 cells and AML-12 cells were cultured over-
night in growth medium containing 100 M FA or 
400 M FA, respectively (complexed 8:1 with BSA). 
BD staining is shown in green and DNA staining 
by DAPI is shown in blue. Scale bar, 10 M. B: One 
million HEK293 cells and one million AML-12 cells 
were cultured overnight in growth medium contain-
ing 100 M or 400 M FA (complexed 8:1 with BSA), 
respectively. Cells were stained with BD using the live 
cell method and then mixed. BDMFI was determined 
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(x-intercepts) is 1,082 for Huh7 cells and 1,891 for U937 
cells. In fact, we have found multiple orders of magnitude 
difference in BDMFI between different types of lean cells 
(data not shown). The observation that there was a consis-
tent lipid-dependent increase in BDMFI indicates that lipid 
levels can be estimated by interpolation using cells with 
known BDMFI and lipid levels. However, as shown in Fig. 3A, 
cell-types differ in lipid-independent BDMFI (BDMFI at 
x-intercept). This necessitates that the cells used to gen-
erate the standard curve have similar lipid-independent 
BDMFI as the cells being assessed.
Standardizing to a specific condition. Normalizing BDMFI 
to a specific treatment condition can be advantageous. 
This mitigates lipid-independent differences in mean fluo-
rescence intensity (e.g., staining conditions, instrument 
type, and settings). The utility of this scheme can be seen 
by comparing Fig. 3B (non-normalized BDMFI) with Fig. 
3C. In Fig. 3C, data from separate experiments was normal-
ized by dividing the BDMFI of cells grown at each level of 
supplemented FA by the BDMFI of cells grown without 
supplemental FA (the lipid-independent BDMFI). There-
fore, this scheme is more precise than interpolating be-
tween cells with known TG levels. However, this scheme 
cannot be used to estimate an absolute lipid mass and even 
relative amounts between samples cannot be estimated 
without knowing the TG-independent BDMFI.
Applications
We used the linear relationship between lipid and BD-
MFI to estimate TG levels in mixed cell populations. First, 
the monocyte cell line, U937, was used as a standard to es-
timate TG in monocytes within human PBMCs (Fig. 4). We 
gated CD14+ cells within the CD11c and HLA-DR double 
positive PBMC population to identify monocytes and then 
determined the BDMFI. In parallel, we determined the 
BDMFI in U937 monocytes with known amounts of TG. We 
fitted BDMFI and TG of the U937 monocytes to a line and 
used this line to estimate that these human monocytes had 
1.94 pg TG/cell.
Fig. 2. BD fluorescence increases linearly with lipid levels. A: AML-12 cells were cultured overnight in 
growth medium supplemented with 0, 100, 200, or 400 M FA (complexed 8:1 with BSA) and were assayed 
for BDMFI or TG using the live cell method. B: U937 cells were cultured for 72 h in growth medium supple-
mented with 0, 100, 300, or 1,000 M FA (complexed 8:1 with BSA) and then fixed. TG was assayed and 
BDMFI determined using the fixed cell method. R2 > 0.99 for both data sets. The negative TG value shown in 
panel A denotes that the absorbance in the TG assay for AML-12 cells was less than the standards with no TG. 
This result likely is due to a compound extracted from the AML-12 cells interfering with enzyme-linked dye 
reductions in the TG assay.
Fig. 3. Normalized lipid levels. A: Huh7 and U937 
cells were cultured overnight in growth medium con-
taining 0, 100, and 1,000 M FA (5.5:1, FA:BSA) and 
cells were then fixed. TG was measured and BDMFI 
was assessed using the fixed cell method. B: AML-12 
cells were incubated with the concentration of FA (8:1, 
FA:BSA) indicated and BDMFI was measured using 
the live cell method (n = 3). C: Data from panel B was 
normalized by dividing the BDMFI at each FA concen-
tration by the BDMFI of the cells grown with 0 M FA.
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Second, we used nontransfected Huh7 cells with known 
amounts of TG to estimate the TG in Huh7 cells transfected 
with RFP-PLIN1. PLIN1 increases TG levels by inhibiting its 
degradation (12).The RFP signal was used to identify the 
cells transfected with this construct (Fig. 5A). As previously 
reported for PLIN1 expression, we found that RFP-PLIN1 
expression increased TG accumulation 10-fold (12) (Fig. 
5B, C). However, within the RFP-PLIN1 transfected popula-
tion, when the best fit line of Huh7 cell standards was used 
to estimate TG mass, the increase in RFP-PLIN1 mean fluo-
rescence intensity did not correlate with an increase in TG 
levels (Fig. 5C). In fact, the low and moderate levels of ex-
pression (gates 2–5) drove the most TG accumulation and 
the highest level was least effective (gate 6). PLIN1 is well-
studied and this lack of dose dependence has not been re-
ported in cell systems. Hence, we confirmed this observation 
by imaging BD-stained RFP-PLIN1 cells transfected in paral-
lel with those analyzed by FC (Fig. 5D). Because 1) this im-
age lacked cells with exceptionally strong RFP signal, 2) 
only 30 cells were shown, and 3) only a few percent of cells 
were in gate 6, we surmise that RFP-PLIN1 levels compara-
ble to gate 6 levels are not likely shown. Consistent with the 
FC data and previous reports, we observed that transfected 
Huh7 cells had more BD staining than those that escaped 
transfection. Further, in the transfected cells (labeled L, M, 
and H), RFP-PLIN1 dose did not correlate with lipid accu-
mulation as assessed by BD signal (Fig. 5D). Interestingly, 
both PLIN1 ablation and its overexpression in mice dimin-
ish their adipocyte TG stores (13–15). This is consistent 
with our FC-based observation that compared with cells 
with no PLIN1 or very high PLIN1 levels, cells with interme-
diate levels of PLIN1 have large TG stores.
DISCUSSION
We show here that the propensity of lipophilic fluoro-
chrome BD to partition into lipid can be used to assess 
intracellular lipid levels. Because this partitioning is an 
intrinsic property of BD, it works on fixed or living cells 
and under a wide range of concentrations. BDMFI can 
be normalized using cells with known lipid mass (Fig. 2) 
or incubated under specific conditions (Fig. 3), allowing 
meaningful comparisons between experiments (Figs. 4, 5). 
We show that using cells with known TG levels as standards 
allows per-cell TG mass to be estimated, and we propose 
that this can be done in any gatable cell population where 
there is a cell type with a comparable amount of nonlipid 
BD fluorescence. This makes estimates of lipid mass in rare 
cell types in a complex tissue feasible. Normalizing by using 
cells with known per-cell lipid masses allows the additional 
advantage of being able to make meaningful comparisons 
between independent studies.
These FC strategies have several advantages over previ-
ous methods. Unlike biochemical assays, FC does not re-
quire an organic extraction, which is tedious and increases 
measurement error. Additionally, biochemical assays are 
prone to interference from non-acyl glycerol in the sam-
ples, as discussed in the report detailing the biochemical 
assay (9), and is demonstrated by the negative value for TG 
in Fig. 2A. Also, this method is more quantitative, more 
objective, and less laborious than imaging strategies. Fi-
nally, because data is collected for each cell, cell-to-cell 
variation in lipid levels is determined. As an example, U937 
monocytes have more variations in BDMFI than monocytes 
from human circulation. This likely is due to the U937 
monocytes being propagated extensively outside the quality 
control mechanisms that maintain the homogeneity of 
circulating monocytes.
Other signals can be determined simultaneously with 
BD giving context to lipid estimates. These include SSC, 
FSC, and a vast and growing number of fluorescently 
tagged lipids, proteins, and antibodies and stains (filipin, 
phalloidin, and DAPI). Further, because FC measures 
these signals in each cell, the relationship between lipid 
Fig. 4. FC can be used to estimate TG in a mixed cell population. A: Human PBMCs were isolated and fixed as described in the Materials 
and Methods. These cells were stained and analyzed in parallel with the U937 cells shown in Fig. 2B. Blood monocytes were identified as 
CD14+ cells gated from the CD45+CD11c+HLA-DR+ population. Then, the BDMFI was measured in the CD14+ population. B: The U937 cells 
that are described in Fig. 2B comprise the red, blue, orange, and light green peaks and have 2.13, 34.7, 98.8, and 160.1 pg TG/cell, respec-
tively. The darker green peak represents the blood monocytes.
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Fig. 5. RFP-PLIN1 transfected Huh7 cells store more TG. Huh7 cells were transfected with RFP-PLIN1 as described in the Materials and 
Methods. Cells were then incubated with 100 M FA (complexed 5.5:1 with BSA) for 18 h and fixed. A: Histogram of RFP signal with six 
gates. B: Histogram of BD fluorescence from panel A gates 1 (red) and 3 (blue). C: Estimate of TG mass of cells from the six gates shown in 
panel A. The Huh7 cells with known TG mass (shown in Fig. 3A) were assessed in the same FC session as the RFP-PLIN1-transfected Huh7 
cells. TG mass versus BDMFI was plotted and the best fit line was determined. This line was used to estimate TG mass in the RFP-PLIN1 
transfected Huh7 cells. D: Huh7 cells transfected with RFP-PLIN1 were treated in parallel as those used for FC. The lipid panel shows the BD 
channel and the DAPI channel and PLIN1 shows the RFP and the DAPI channel. The BD signal is teal, RFP signal is pink, and DAPI signal 
is yellow. H, M, and L indicate high, medium and low levels of RFP.
levels and these other signals can be assessed in a single 
cell-type in a mixed cell population. This context allowed 
the novel observation that the previously described PLIN1-
driven TG accumulation requires only low levels of PLIN1 
and higher PLIN1 levels have a lesser effect on TG accumu-
lation than lower levels (Fig. 5).
BD is hydrophobic and labels lipid by partitioning into 
the cellular lipid. This partitioning is independent of bio-
logic processes. Because BD partitions into all hydrophobic 
compartments, it detects total lipid mass with little regard 
to neutral lipid types. Because TG is the long-term energy 
store for animals, it represents the bulk of the lipid in most 
animal tissues. Thus, TG and total lipid mass usually are 
similar. However, this is not true for some specialized cells 
that have a significant fraction of other neutral lipid species, 
such as monoalkyl-diacylglycerol, cholesterol esters, and 
retinal esters. This method allows total lipid to be measured 
in a single cell type, which may be dissimilar to neutral lipid 
composition of the tissue. For example, adipose macro-
phage neutral lipid composition may have little resem-
blance to the whole adipose tissue. However, because a 
detailed understanding of the lipid composition within a 
cell is resource intensive and total lipid levels (steatosis) 
often correlate with metabolic disease (1–5), this single 
parameter description of lipid levels may be advantageous.
This method allows estimation of lipid mass by using 
cells of similar size and known BDMFI and average TG 
mass/cell. Figure 3A shows that cell size affects non-TG-
dependent BDMFI (the intercept of the line), but does 
not affect the TG-dependent increase in BDMFI. This 
can allow reasonable estimates of cellular TG mass. How-
ever, it is important to have similar nonlipid BDMFI, 
especially in lean cells where the ratio of nonlipid to lipid 
BDMFI is high. For example, estimating lipid mass in the 
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human monocytes shown in Fig. 4 illustrates this concept. 
The larger cultured monocytes have a higher nonlipid BD-
MFI than primary monocytes and, as a result, too little of 
the BDMFI in primary monocytes is attributed to lipid, 
making the interpolated lipid mass an underestimate. Us-
ing this strategy appropriately, we show that RFP-PLIN1 
expression increased TG accumulation, which was previ-
ously observed (12). However, this experiment also indi-
cates that accumulation is maximal at moderate RFP-PLIN1 
levels and very high levels of expression inhibit TG accu-
mulation (Fig. 5C). Despite the intensive study of PLIN1, 
this has not been reported, although, as mentioned above, 
in vivo studies showed that overexpression diminished adi-
pocyte TG stores (14). This strategy makes it feasible to 
assess the effect on lipid levels of proteins that cannot be 
stably expressed. In addition, the relative potency of differ-
ent proteins on lipid levels can be assessed by using the 
same fluorescent tag (e.g., RFP) on each protein to deter-
mine and match the levels of the proteins of interest.
In summary, we report a method to assess lipid mass in 
single cells by FC. The utility of this method is enhanced by 
existing FC methods and reagents to assess many cellular 
parameters (e.g., apoptosis, cholesterol levels, and surface 
antigens) that can be contemporaneously employed. Fur-
ther, other neutral lipid staining fluorophores with differ-
ent spectrums can be utilized when autofluorescence or 
the measurements of other parameters preclude the use of 
the FITC channel.
The authors thank Liz Miller for help with the blood draw, 
Dr. Douglas Mashek for providing cell lines, Dr. Gordon Smith 
for providing the blood for the monocyte studies, Dr. Anja 
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